Placeholder Image

字幕列表 影片播放

  • The following content is provided under a Creative

  • Commons license.

  • Your support will help MIT OpenCourseWare

  • continue to offer high quality educational resources for free.

  • To make a donation or view additional materials

  • from hundreds of MIT courses, visit MIT OpenCourseWare

  • at ocw.mit.edu.

  • JOANNE STUBBE: What I want to do is sort of introduce you

  • to the second half of the course, where we're going,

  • and what topics we're going to be covering.

  • And then I'll start in module 5.

  • So as with the first half of the course, we have four modules.

  • The first half the courses was pretty well organized--

  • that is, you went from here to here to here.

  • It all sort of made sense.

  • This half of the course doesn't do that.

  • We're talking about-- there are hundreds

  • of topics in biochemistry, and any one of them

  • is exciting and important.

  • And these are the ones we're talking about this semester.

  • And again, the focus will be sort

  • of trying to get you to think about,

  • what is the evidence that supports

  • the model I'm going to present.

  • So in module 5, we're going to be talking about the terpenome.

  • And I'm going to be talking about, most of you

  • have seen in the last module, with polyketide synthases,

  • you have aldol reactions and claison reactions

  • to form carbon carbon bonds.

  • In this module, you're going to be introduced to another way

  • to form carbon carbon bonds.

  • And that's through C5 units.

  • And C5 units are the basis for forming cholesterol, which is

  • really the focus of module 5.

  • And what we're going to be talking about

  • is initially cholesterol biosynthesis,

  • that will be this lecture and probably

  • most of the next lecture.

  • And then you all know from eating McDonald's hamburgers,

  • you get a lot of cholesterol in your diet.

  • And the question is, how do you control cholesterol levels?

  • And so this semester, the second part of the semester

  • is really focus on the question of homeostasis.

  • Cholesterol is essential.

  • If you have too much you've got problems.

  • Doesn't matter what pathway you're talking about,

  • if you have too much or you have too little, you have problems.

  • So how do you control everything?

  • And we're going to be talking about cholesterol sensing

  • and regulation.

  • And we're going to come back to a topic you covered

  • in the first half of the course with ClpX and ClpP protein

  • mediated degradation, because it plays

  • a central role in controlling cholesterol homeostasis.

  • So that will be the first module, module 5.

  • Module 6 is also going to be a module on homeostasis.

  • It's my feeling that in introductory courses,

  • people don't get introduced enough to metals.

  • And 50% of all the proteins inside of us

  • bind metals and do something with them.

  • And so in this module, I'm going to talk

  • about metal homeostasis.

  • And I'm really going to focus on iron.

  • And you'll see why I'm going to focus

  • on iron when we get there.

  • But we're going to talk about iron sensing and regulation,

  • initially in humans, and then we're

  • going to focus on the war between pathogenic organisms

  • for iron and humans for iron, since iron

  • is essential for almost all organisms to survive.

  • The third module is sort of--

  • module 7-- sort of follows from module 6.

  • And it's a topic that I've been following for 30 years,

  • and it irritates the hell out of me.

  • So everybody talks about reactive oxygen species,

  • and how bad they are.

  • You can't-- you can listen to NPR,

  • you can read it in The New York Times.

  • What are reactive oxygen species?

  • As a chemist, what are they?

  • So we'll define what reactive oxygen species are.

  • Many of you know that they're bad.

  • That's why you eat vitamin C and vitamin E.

  • And they're involved, in fact, in defense

  • against some microorganisms.

  • But also they're good.

  • They're now known to be involved in signaling.

  • So again, it's a question of homeostasis.

  • And so you need to understand the chemistry

  • of what these species do, and where they can go astray,

  • or where you can harness the reactivity

  • to do something important.

  • And the last section-- hopefully we'll get there this year,

  • I'm trying my best--

  • this is the area I know most about,

  • we're going to talk about nucleotide metabolism.

  • In 5.07, they don't talk about nucleotide metabolism at all.

  • And I would say in the next decade,

  • you're going to see a lot about nucleotide metabolism.

  • Where have you seen ATP and GTP in the first part

  • of this course?

  • Everywhere.

  • How do we control all of that?

  • Pretty important.

  • What are the questions we're going to be asking?

  • Where does it come from?

  • And how do we control the levels,

  • which is central to all of metabolism?

  • Hopefully we'll get there and discuss that.

  • So the required reading has now been posted on Stellar.

  • And there are-- there is really sort of three

  • things you need to read.

  • One is about a short review on the terpenome, which

  • is what I'm going to start talking about.

  • The second is lipid metabolism that's

  • been taken from Voet & Voet, you can

  • go back in any basic textbook and read the section,

  • because it's central to thinking about what's

  • going on with cholesterol.

  • And then you'll see that these are

  • two of my favorite guys, Brown and Goldstein.

  • They won the Nobel Prize for their work,

  • but in reality they should have won at least two Nobel prizes

  • for their work.

  • I mean, you can never not listen to them talk

  • and not get excited.

  • I mean, they always have something

  • important and exciting to say.

  • So they-- last year we used this review.

  • There's a new review.

  • They're different, they're both pretty short.

  • Pick which one you want, they cover the material.

  • And then this one doesn't cover the most recent material

  • as well.

  • So here's another short review that covers that material.

  • So these guys here will give you an overview of what

  • I'm going to be talking about.

  • And they've all been posted on the website already.

  • So cholesterol homeostasis--

  • I never end a lecture on time.

  • You'll find out that I'm trying my best, anyhow.

  • We have about five lectures we're going to be covering.

  • And this is where we're going.

  • And the first one, today's lecture, we're

  • going to be talking about a new way

  • to form carbon carbon bonds through C5 units.

  • And we'll be talking about the terpenome, where

  • there are a huge number of natural products,

  • distinct from polyketide synthases

  • and non-ribosomal polypeptide synthases

  • that you just finished talking about.

  • We want to get to-- we'll see in the biosynthetic pathway

  • to get to these C5 building blocks,

  • we need to get to a metabolite called mevalonic acid, that's

  • front and central in cholesterol biosynthesis.

  • So we need to get that far.

  • And then we need to get from mevalonic acid

  • into cholesterol.

  • And so we'll be talking about this the first couple

  • of lectures.

  • In addition to making cholesterol,

  • you get a lot of cholesterol from your diet.

  • And so the question is, how does it

  • get from your diet, transferred through the plasma,

  • and taken up into cells?

  • And this section, we'll describe the discovery

  • of receptor mediated endocytosis,

  • by Brown and Goldstein, that's now known

  • to be prevalent everywhere.

  • So the module-- module 6, you take up

  • iron by receptor mediated endocytosis.

  • In module 7, growth factors are involved in receptor mediated

  • endocytosis.

  • So it represents a general paradigm

  • that happens all the time over and over again in biology.

  • And then we're going to ask the question,

  • how do you sense the cholesterol?

  • And we're going to be doing two recitations on this.

  • And then we'll have a few lectures on the machinery

  • that sense cholesterol sterile responsive binding proteins,

  • in a molecule called SCAP, and another molecule--

  • both of these are proteins-- called INSIGs.

  • Everything is located in a membrane-- that's something

  • you haven't been exposed to.

  • How do you control everything when you

  • have stuff stuck in a membrane.

  • And then we'll come back at the end

  • to look at the rate limiting step

  • in formation of mevalonic acid, HMGCoA reductase,

  • and how that plays a key role, since it's

  • involved in making cholesterol.

  • How do we control and regulate that protein, also

  • in the ER membrane.

  • And we'll see it requires ubiquitin mediated protein

  • degradation.

  • And so that's why I'm going to come back,

  • and we're going to spend a little bit of time

  • talking about this process in eukaryotic systems.

  • And actually, in all the other modules,

  • you're going to see ubiquitin mediated protein degradation.

  • And finally, this week in recitation, there's a new--

  • not new, it was discovered in 2003--

  • a new target for drug therapy in controlling cholesterol levels.

  • And there was a paper published this year

  • to show that this is, in fact, a good target.

  • And this paper used CRISPR-Cas9 technology.

  • So I'm going to--

  • even though I'm not an expert in that, my lab hasn't used it--

  • I'm going to introduce you to this technology,

  • and then focus on why we think this is a good new target,

  • and what the targeting is.

  • So that's where we're going.

  • So the terpenome-- let's see if I can

  • remember what I'm going to say.

  • The first thing I want to say is-- let me just get all this--

  • OK, the first thing I want to tell you something about

  • is the nomenclature--

  • and all terpenes are either called

  • isoprenoids or terpenoids, and they're all made from C5--

  • a C5 hydrocarbon skeleton.

  • And this C5 hydrocarbon skeleton is an isoprene.

  • So this is the key building block

  • that you're going to see over and over again

  • over the course of the first couple of lectures.

  • So an isoprenoid is, in general, linear.

  • And it's made of n of these C5 units.

  • So n can be 2 to thousands.

  • And I'll give you examples of these.

  • And again-- and then the terpenoids--

  • so let's just use terpenoids over here--

  • in general are also made of C5--

  • C5 units.

  • But often, they're oxidized, cyclized,

  • and sometimes rearranged.

  • So my goal today really sort of is introduce you

  • to this huge class of natural products.

  • And give you some examples of this,

  • and then start focusing on how we get the building blocks.

  • Do you think iso--

  • this isoprene can be a building block?

  • It's chemically not very reactive.

  • So no, we have to convert--

  • we have to convert this into the chemically reactive building

  • block.

  • So while isoprene gives you the C5 unit,

  • our focus today is going to be on creating the building

  • blocks.

  • And again, the building blocks are going to be--

  • these are the guys you're going to see over and over again.

  • 1, 2, 3, 4, 5--

  • so does everybody know what PPI means, so I

  • don't have to write it out?

  • pyrophosphate-- we're going to see this over and over again.

  • You've seen this in the first part of the semester.

  • And this isopentenyl pyrophosphate, or IPP.

  • And we're going to see this--

  • if you look at this this hydrogen, what's

  • interesting about this hydrogen, chemically?

  • What's the pKa of that hydrogen, compared

  • to if it was this hydrogen?

  • It's much lower.

  • Yeah, so it can form allylic cations or anions.

  • And so this can readily isomerize

  • to form this species, which also plays,

  • which is dimethylalyl pyrophosphate, which

  • is the other key building block that we're

  • going to be looking at.

  • So currently, it's estimated from the latest paper

  • that I've read that these are the building blocks for what

  • we call the terpenome.

  • And it's estimated that there are greater than 70,000

  • natural products.

  • Now in contrast to what you've learned

  • about with non-ribosomal polypeptides

  • synthases and polyketide synthases,

  • where you sort of can find everything in an operon,

  • and you can sort of understand how your molecules could

  • be put together.

  • It's not so trivial with terpenes.

  • There is no such logic in these systems.

  • So let's just look at what some of these molecules

  • actually are so you know why they're important.

  • And, OK, so so in the center of everything

  • are these two guys, our two building blocks.

  • And these building blocks can go to the fat soluble vitamins--

  • so for example A and K. So if you look over here,

  • you have vitamin A--

  • I knew this was going to happen.

  • My late-- my pointers are not working very well.

  • I need-- OK, so anyhow you have vitamin A and you have vitamin

  • K. And where do you see-- you can

  • see here readily that you have these C5 units somehow

  • stuck together.

  • And you have to ask the question,

  • where does the rest of this come from?

  • So fat soluble vitamins, which we're not

  • going to talk about, what you also have

  • is prenylated proteins.

  • And prenylated proteins are shown here.

  • So quite frequently, you have small little g

  • proteins, GTPases, you've seen these before.

  • EFTU, EFGG, they're all over the place.

  • There are hundreds of g proteins--

  • we talked about them in the recitation section on Rodnina

  • that I gave you.

  • Anyhow, a lot of those little g proteins go to the membrane

  • and come away from the membrane.

  • They do that by sticking on a tag.

  • This tag can be geranylated or gerynalgeranylated--

  • it just the hydrophobic tag that allows

  • things to interact with the membrane,

  • increasing the effective molarity.

  • Nature uses this trick over and over and over again.

  • Another thing you can generate is natural products

  • of medicinal interest.

  • And I just show here taxol and artemisinin.

  • So taxol is used in the treatment of breast cancer.

  • Artemisinin, anybody heard of that?

  • Yeah, so this has been the major target--

  • in fact, this pathway we're talking about today

  • has been a major focus of many synthetic biologies,

  • trying to make this mevalonic acid pathway

  • so they can make potential drugs, but also jet fuels--

  • which, again, you want some kind of hydrocarbon.

  • So this pathway has been studied a lot

  • from a point of view of metabolic engineering.

  • It's also involved in--

  • this is one of my favorite-- the perfume.

  • You can tell from the way I smell the perfume industry.

  • Any of you ever break a pine cone?

  • A pine needle?

  • Yeah, doesn't it smell great?

  • No, you don't think so?

  • I think it's wonderful.

  • It's called pinene.

  • Anyhow, it has--

  • I think terpenes wonderful smells,

  • and it's the hallmark of the fragrance industry.

  • Is that on here?

  • Yeah, so menthol.

  • Limonene is orange-- in fact, if you were here when Barry

  • Sharpless used to teach--

  • I can't digress, because that's why I never

  • get to the end of the course.

  • But anyhow, Barry used to bring to organic class--

  • he had boxes of smells.

  • And he used to pass around the smells,

  • and they were all wonderful.

  • And they were almost all terpenes.

  • And we're going to be looking at things

  • like dolichol-- we aren't going to be looking at it.

  • We will see it a little bit.

  • But what you can see here, Suzanne Walker

  • is giving a talk here April 4th.

  • And she works on--

  • one of the things she works on is peptidoglycan biosynthesis.

  • And so sugars are carried around on these lipids.

  • Some of them are C19 to C55.

  • If you look at these, you can see these little units

  • stuck together.

  • Barbara Imperiali, in our department, the biology

  • department, works on a asparagine-linked

  • glycosylation.

  • Again, the sugars are carried around

  • by these kinds of terpenes.

  • So plays a central role in putting sugars onto systems.

  • And then what we're going to be focused on today--

  • and this is the focus in general--

  • is on cholesterol.

  • Do I have that up there?

  • I think so.

  • So what we're going to-- do I have cholesterol up there?

  • Yeah.

  • OK, here it is.

  • Cholesterol.

  • That's what we're going to be focusing on.

  • And that's not a C5, But a C30.

  • So how do we get from these C5 units into the C30 units?

  • So that's an introduction to the terpenome.

  • They're everywhere.

  • And so you can't become a biochemist

  • without seeing carbon carbon bond formation by these C5

  • units, in many, many kinds of reactions--

  • in both primary and secondary metabolism.

  • They're very important.

  • So what I want to do before we get

  • into looking at one of the pathways

  • that you can make the building blocks, IPP and DMAPP--

  • this is abbreviated DMAPP.

  • One of the ways is through the mevalonic acid pathway,

  • and here's a picture of a cell that I took from something

  • off the web.

  • But I want to introduce you to where we're going to be going,

  • cholesterol biosynthesis.

  • So where do we break down fatty acids?

  • Does anybody know?

  • You remember from your introductory course?

  • I want to try to put this into the big picture on metabolism,

  • so you're not-- we're just not pulling it out of the air.

  • Anybody know where you break down fatty acids from the diet?

  • AUDIENCE: You're asking in the cell, specifically?

  • JOANNE STUBBE: There in the cell.

  • Yeah, where in the cell?

  • These are-- we're talking about eukaryotes now.

  • Bacteria don't make cholesterol.

  • Yeah.

  • What?

  • OK, you don't even know that.

  • OK, so you should go back and read the chapter

  • on fatty acid biosynthesis and degradation.

  • That would be a good thing for you to do.

  • Anyhow, fatty acids are broken down in the mitochondria.

  • We'll see this in a second.

  • So the mitochondria play a role.

  • We're going to see today--

  • so here's the nucleus, here's the endoplasmic reticulum.

  • The endoplasmic reticulum is the key sensor

  • in cholesterol homeostasis.

  • And so we're going to-- and we're

  • going to see that it controls transcription factors.

  • Transcription factors are stuck in a membrane in the ER.

  • That's-- how weird is that?

  • Because where do transcription factors need to go?

  • They need to go to the nucleus.

  • So how can you do that?

  • How can you take something stuck in a membrane

  • and get it to the nucleus?

  • So they need to go through a golgi stack.

  • They do some stuff we're going to learn about

  • to eventually get into the nucleus, where they control

  • not only the levels of cholesterol proteins,

  • but also of metabolism of phospholipids,

  • triacylglycerols.

  • so this takes us into the big realm of all lipid metabolism,

  • which most of the time people don't

  • spend a lot of time talking about

  • in an introductory course.

  • And I mean, one of the interesting questions--

  • we're going to see the key rate limiting step

  • in cholesterol homeostasis.

  • The protein is bound to the ER membrane,

  • and a lot of the proteins involved

  • in cholesterol biosynthesis are in the ER membrane.

  • 50% of all the cholesterol ends up in the plasma membrane.

  • how does it get there?

  • Does it just go through solution?

  • You need to think about the properties of cholesterol.

  • So when you get confused about where we're going,

  • come back to the picture.

  • And I'm going to show you one other big picture, which

  • we use when I teach--

  • when I've taught 5.07 with Essigmann-- again,

  • this is the picture we can back to over

  • and over and over again.

  • Because everything is interconnected.

  • So we're going to be talking about cholesterol biosynthesis.

  • We're going to see a key player is acetyl-CoA.

  • Where have you seen that?

  • You've learned a lot about acetyl-CoA in biosynthesis,

  • and use in biosynthesis and polyketide.

  • Synthases, you talked about biosynthesis of fatty acids.

  • So fatty acids are biosynthesized in the cytosol.

  • But I just told you fatty acids are

  • degraded in the mitochondria.

  • What are they degraded to?

  • Degraded to acetyl-CoA.

  • Can acetyl-CoA get from the mitochondria to the cytosol?

  • Nobody knows?

  • Let's get some energy, you guys.

  • What do we know about acetyl-CoA?

  • AUDIENCE: [INAUDIBLE]

  • JOANNE STUBBE: It's what?

  • AUDIENCE: A transport system [INAUDIBLE]----

  • JOANNE STUBBE: So you think is the transport

  • system that takes it from the mitochondria to the cytosol.

  • So that's wrong.

  • And in fact, this is again another thing

  • that I think maybe isn't emphasized enough

  • in an introductory course.

  • A lot of these things cannot transfer across these

  • membranes.

  • So-- and this may or may not be logical to you,

  • when you take this and you're saying,

  • oh my god, this is so complicated.

  • It's really not that complicated when

  • you put all primary metabolism into the big picture.

  • Acetyl-CoA goes into the TCA cycle,

  • and it condenses with oxaloacetic acid

  • to form citric acid.

  • We're going to see citric acid again with iron homeostasis.

  • Anyhow, it's citrate that is able to go

  • across the mitochondrial membrane,

  • as is malate, as is pyruvate.

  • Acetyl-CoA is not able to do that.

  • And so to get acetyl-CoA, then you

  • have to enzymatically break down citrate.

  • So if you don't know what citrate is,

  • it's a central metabolite.

  • You're going to see it again and again.

  • Pull it up, Google it.

  • Put it in your brain.

  • You form acetyl-CoA.

  • An acetyl-CoA, as you learned in the first part of course,

  • can form fatty acids.

  • Where do fatty acids go?

  • They can attach to glycerol.

  • And where does glycerol come from?

  • It comes from breakdown of sugars

  • through the glycolosis pathway.

  • And they come together to form phospholipids, which

  • make up all our membranes.

  • Pretty important.

  • What else can fatty acids do?

  • They can interact with glycerol without a phosphate,

  • to triacylglycerols.

  • Triacyl-- esterified triacylgycerols.

  • Does everybody know what glycerol is?

  • Everybody know?

  • OK, so-- and this is another thing we're going to find.

  • We have huge amounts of phospholipids

  • and triacylglycerols in our diet.

  • So we have to deal with those things.

  • But acetyl-CoA, we'll also see, is the building block

  • to form mevalonic acid through a pathway we're

  • going to describe now.

  • So mevalonic acid is a key player,

  • and its formation is rate limiting

  • in cholesterol biosynthesis.

  • The enzyme that makes mevaloinc acid

  • is located in this little messy thing here, and that's the ER.

  • So it's bound to the ER.

  • It makes cholesterol.

  • And then ultimately, how does cholesterol move--

  • and a lot of the precursors to cholesterol stay

  • solubilized, and then get distributed

  • to all the membranes.

  • 50% of the cholesterol, for example,

  • is found in the plasma membrane.

  • So that's the big picture.

  • And so when you get confused about where we're going,

  • you need to go back and see how central a player

  • acetyl-CoA is to everything.

  • And so its regulation, you're going to see,

  • is governed by the same transcription

  • factors that regulate cholesterol homeostasis.

  • Because they were all linked.

  • So where are we going?

  • Let's see if I can remember where we're going.

  • So where are we going?

  • So I'm giving you an overview of where we're going.

  • And I'm only-- this is a long pathway to get to lanosterol.

  • I'm not going to look at all the steps in the pathway.

  • I'm just going to tell you how we use these C5

  • units to generate terpenes.

  • So we've got to get to the C5 units over here.

  • We've got to get to these two intermediates.

  • And then we're going to use them to get eventually to a C30.

  • And we'll see the same chemistry,

  • once we know a few rules, just like with aldol reactions

  • and claison reactions, are used over and over and over again.

  • There are a few basic rules.

  • Every protein is different, but I'm

  • going to make sweeping generalizations, which

  • is a good place to start.

  • So we have to use three molecules of acetyl-CoA.

  • So you're all-- you all should be

  • very familiar with acetyl-CoA.

  • And we're after trying to form C5.

  • So three of these gives us C6, so we

  • have to get rid of a carbon.

  • So from this we need to lose whatever the pathway is.

  • It turns out we lose one carbon as CO2.

  • And this whole process--

  • so this can be multiple steps--

  • is called initiation.

  • And it forms IPP, which can isomerize to form DMAPP.

  • And then, again, this is our C5 unit that we're after.

  • So this is C5.

  • And we've lost one carbon as CO2.

  • So then we're going to have what I'm going to call elongation.

  • And what we're going to see is that to get to lanosterol,

  • all we need to have a C30.

  • So we need six of these guys.

  • So we have six C5 to form a C30.

  • Which is lanosterol.

  • This is a precursor to steroids.

  • [INAUDIBLE] talk about cholesterol-- uh oh.

  • I knew that that was going to happen.

  • I jump around.

  • Usually this falls off, so you'll

  • have to get used to this.

  • It's a good thing--

  • I spent all morning trying to figure out where the--

  • where this cord came, because I knew

  • my cord wasn't going to fit, and the cord was going to be shot,

  • and then I was thinking, how am I going to run from one door

  • to the next?

  • I need to get this back on me.

  • Can you hear me?

  • OK.

  • Let me get back on gear.

  • So C30-- but then what's going to happen--

  • so we get to lanosterol, and then from lanosterol,

  • and going to lanosterol here, we're going to have to do,

  • like, I think, the most amazing chemistry in the whole world.

  • We're going to have to do an oxidation and a cyclization.

  • So this is going to be a terpene.

  • So we're going to put these things together

  • to form a C30, a linear C30, and then

  • they have to come together to form this guy.

  • So we're going to talk about this reaction,

  • because it's such a cool reaction.

  • Anyhow, we're going to talk about how this linear molecule

  • gets to this.

  • That's-- that is the coolest reaction, in my opinion,

  • in biology.

  • I remember when I first heard about this when I

  • was in graduate school in 1968.

  • A long time ago.

  • That's what made me decide I didn't

  • want to be an organic chemist.

  • I said, how amazing is this?

  • That you can do one step and you can

  • put in all of these asymmetric centers and 100% yield.

  • So that was it.

  • That was a turning point in my life.

  • Anyhow, hopefully it'll be a turning point in your life too.

  • So we have C30.

  • And then we're not there yet.

  • So this is going to be, for us, the--

  • after the elongation, these cyclizations and oxidation

  • is going to be the termination to get to this ring structure.

  • But then to get to cholesterol, we have 19 more steps.

  • So this is really complicated pathway.

  • And I'll tell you what had the chemistry actually is not

  • so hard to understand, but the details are really

  • still not understood.

  • Because all of the proteins are membrane bound.

  • So what I want to do now is come back over here.

  • And we're going to talk about initiation, elongation,

  • and the termination steps.

  • And I'm going to focus on a few of the reactions

  • that I think are important, and a lot of the details

  • are written down--

  • are written down on the PowerPoint.

  • So let's look at the first few steps.

  • And so let's start the pathway.

  • And the first molecule we're dealing with is acetyl-CoA.

  • And what is special about acetyl-CoA.

  • Why is nature-- you've just had a whole bunch of units

  • on acetyl-CoA-- why does nature use thioesters?

  • What are the two key things you need

  • to think about in terms of its reactivity?

  • You guys should be experts on this now.

  • Yeah?

  • AUDIENCE: There's a low pKa [INAUDIBLE]..

  • JOANNE STUBBE: Right, so you have a reduced pKa,

  • is reduced from, say, 22 to 18.

  • So this is the alpha hydrogen acidity.

  • And what else does a thioester do?

  • What is the other reactive part of CoA?

  • This should be like the back of your hand.

  • I mean, this is part-- this is central to everything

  • in biochemistry.

  • Yeah.

  • AUDIENCE: [INAUDIBLE]

  • JOANNE STUBBE: Pardon me?

  • AUDIENCE: The leaving group.

  • JOANNE STUBBE: The leaving group.

  • You are going to have a leaving group.

  • But that's-- and that is important,

  • but that's not the key important thing.

  • That is a part of the game.

  • It can drive the reaction to the right,

  • if you look at the free energy of hydrolysis.

  • What else is activated when you have a sulfur ester as opposed

  • to an oxygen ester?

  • AUDIENCE: Carbonyl.

  • JOANNE STUBBE: The carbonyl, because of the decreased

  • resonance stabilization.

  • So what you've done then is you have activation

  • for nucleophilic attack.

  • And you see this-- nature uses this

  • in cholesterol homeostasis as well,

  • over and over and over again.

  • So in the first step, and I'm not going to draw out

  • the details, what you can see here is that you're taking two

  • molecules of acetyl-CoA and you're forming

  • acetoacetyl-CoA--

  • that should be good practice for you

  • for thinking about the exam on Wednesday.

  • And this is an example of a claison reaction,

  • one of the three types of mechanisms,

  • to form carbon carbon bonds.

  • The next step, we need three acetyl-CoA's

  • to get eventually to isopentenyl pyrophosphate and dimethylallyl

  • pyrophosphate.

  • So we're going to use another molecule on acetyl-CoA

  • to form hydroxymethylglutaryl-CoA.

  • So we need to add another one of these guys.

  • And this is HMG-CoA synthase.

  • So before I go there, let's go through what we know.

  • So this is-- so we're starting here.

  • So here-- acetyl-CoA plays a central role.

  • Why thioesters?

  • It's important in claison reactions.

  • Here's the example of a claison reaction involving

  • a carbanion intermediate that you guys should all be experts

  • at at this stage.

  • What about this step?

  • The next step?

  • Formation of hydroxymethylglutaryl-CoA?

  • So here it turns out that this enzyme uses covalent catalysis.

  • Frequently enzymes-- you've already seen this as well,

  • we're going to see this again and again over the course

  • of the rest of the semester.

  • One of the major mechanisms of rate acceleration

  • is covalent catalysis.

  • Here the thioester-- the CoA ester has been removed

  • and it's attached to a cysteine in the active site

  • of the enzyme.

  • And then this can react with, in this case,

  • a ketone like molecule in an aldol reaction.

  • So here's the second example.

  • We take acetoacetyl-CoA.

  • We add another CoA.

  • And what we form, then, is hydroxymethylglutaryl-CoA.

  • And what we're going to see is, during this reaction,

  • we also have to do a hydrolosis reaction.

  • Because we start out with acetyl-CoA and we only add--

  • end up with a single thioester.

  • And this reaction forms hydroxymethylglutaryl-CoA.

  • So we've lost-- in this reaction over here,

  • you can see where this is lost.

  • So you have an acetyl-CoA to form the thioester

  • in the active site.

  • You you've lost a CoA.

  • Is everybody with me?

  • So you're using the third molecule of acetyl-CoA.

  • You've already lost the CoA.

  • And then what you end up with in the end

  • is you have to hydrolize this off.

  • So if you didn't realize it went through a covalent

  • intermediate, it would be like you just

  • lost a CoA, which you did.

  • But you lost it in this step, because you

  • went through a covalent intermediate.

  • And you're not responsible for the details.

  • Many, many enzymes that use acetyl-CoA go through covalent

  • intermediates just like this.

  • But you have to study each one to figure out why they do that.

  • Why do they do that?

  • Because covalent catalysis gives us rate accelerations of 10

  • to the 4th, 10 to the 5th.

  • So nature has used that as a repertoire

  • of defining how to catalyze reactions at amazing rates.

  • So now we're at this stage.

  • And the next step in this pathway--

  • so we're still trying to get to the C5 over here.

  • And to get to this now, we're going

  • to have to do a reduction.

  • And we're trying to get to--

  • so we did this reaction here.

  • I will fix my thing for next--

  • OK.

  • So now what we're doing is we're going

  • from hydroxymethylglutaryl-CoA to mevalonic acid.

  • And this is wrong.

  • They should all be NADPHs.

  • When you're doing biosynthesis, what do you use?

  • You don't use any NADH.

  • You use NADPH in almost all biosynthetic pathways.

  • So what happens?

  • You're reducing, basically, the thioester down to--

  • a thioester down to an alcohol.

  • Everybody should know at this stage how this kind of reaction

  • goes.

  • Everybody, this is one of the two major redox co-factors

  • and all of biology.

  • Can somebody tell me how this redox reaction goes?

  • This is one of the vitamins on your bottle, niacin,

  • which gets metabolized into NAD, NADP.

  • How does that do a reduction?

  • Can somebody tell me?

  • Yeah.

  • AUDIENCE: Form an aromatic ring by eliminating the hydride--

  • so the hydride attacks the--

  • JOANNE STUBBE: Right, so that's it.

  • And where does the hydride attack?

  • AUDIENCE: The carbonyl.

  • JOANNE STUBBE: What part of the carbonyl?

  • AUDIENCE: The carbon.

  • JOANNE STUBBE: Yeah, OK.

  • So this is something that I fight with kids all the time

  • in 5.07.

  • It doesn't attack the oxygen. It attacks the carbonyl

  • because it's polarized delta plus delta minus.

  • So you have-- this, again, of all the vitamins

  • on your vitamin bottle, this is the simplest one.

  • So hydrogen moves with a pair of electrons

  • that's called the hydride, to do this reduction.

  • And over here, I think I have the details written out.

  • So I'm not going to write this out in more detail.

  • But you generate this intermediate--

  • this intermediate--

  • this intermediate may-- or the oxygen may or may not

  • be protonated.

  • You need to look in the active site of the enzyme.

  • But then what happens to this intermediate?

  • This intermediate-- so tetrahedral intermediate's

  • not very stable.

  • It can break down to liberate CoA.

  • And what are you left with?

  • You're left with an aldehyde.

  • So that's one reduction.

  • And where do we want to go?

  • Where we want to go--

  • and so I'm not going to draw the whole thing out,

  • but I'll draw a part of this out--

  • so this gives us, then, through a tetrahedral intermediate,

  • an aldehyde.

  • And then what can happen to the aldehyde?

  • We use another molecule of NADPH?

  • And what happens with that?

  • The same thing.

  • You now do a hydride transfer.

  • And so we need another molecule of NADPH to form the alcohol.

  • So this is a mevalonic acid.

  • So this is written out in more detail

  • here, for those of you who have trouble trouble thinking

  • about this.

  • But of all the factors that nature

  • has evolved to help us expand the repertoire of reactions

  • in biology, NADPH--

  • NADH is the simplest.

  • Hydride-- it's always hydride.

  • Flavins, much more complicated.

  • We'll see some of those-- the chemistry is much more

  • complicated.

  • This is really straightforward.

  • So what do we know about this?

  • Why are people interested in this?

  • And this enzyme is called HMG-CoA reductase.

  • And in your handouts, it's abbreviated--

  • I think these things are terrible.

  • I will give you a list with all the acronyms on them.

  • I can't remember the acronyms.

  • And people change them.

  • And people name things-- enzyme names are extremely difficult.

  • The older they are, the worse the issue is.

  • Because do you know what NAD used to be called?

  • Any of you have a memory of that?

  • Any of you read the old literature?

  • It used to be called DPN--

  • dipyridine nucleotide.

  • So this is pyridine, and that's where they got the name from.

  • And I used to teach with somebody, [INAUDIBLE]

  • a long time ago, and everything was DPN.

  • So anyhow, if you've read the literature,

  • nothing will be called in NAD, NADH.

  • And in fact, a lot of the seminal experiments

  • that elucidate the pathways came out of the old literature.

  • So why is this protein interesting?

  • So we're going to spend a little bit of time on this protein.

  • People have spent a huge amount of time looking

  • at this protein in detail.

  • Does anybody know why?

  • AUDIENCE: [INAUDIBLE] people target it-- like statins

  • target it, or cholesterol.

  • JOANNE STUBBE: So the key thing in this system

  • is it's the rate limiting step in cholesterol biosynthesis.

  • And it's the target of, I would say,

  • a wonder drug-- the wonder drugs of the statins.

  • So people really care about the detailed mechanism.

  • We don't care about the detailed mechanism.

  • We do care that hydride attacks the carbonyl,

  • and it attacks the carbon and not the oxygen.

  • But the details, if you're interested in that,

  • you can go read about this in the reference.

  • A lot of people have focused a lot of energy

  • on this, trying to make better statin inhibitors.

  • So what do we know about this?

  • And there's a few things I want to say about this.

  • And so if we look at the protein,

  • we're going to come back to this in lecture 3.

  • So this is important to remember.

  • So this is the protein.

  • I'm going to use this cartoon.

  • And Liz used these cartoons as well.

  • But what we're going to see is the protein

  • has eight of these things--

  • eight.

  • Each one of these things--

  • OK, [INAUDIBLE],, and we need three more.

  • I'm not going to fit this.

  • So it has a transmembrane helices.

  • And the protein itself is, again, 888 amino acids.

  • And what's interesting about this,

  • if you have this many transmembrane helices, where's

  • the protein going to be located?

  • It's going to be located in a membrane.

  • So these five are called the sterile sensor domain.

  • HMG-CoA reductase is going to be a key player in regulation

  • of cholesterol levels.

  • And it exists-- it's found, this protein

  • is found in the ER membrane.

  • And SSD is the sterile sensor domain.

  • And we're to come back to this when we start

  • talking about homeostasis.

  • We're going to see that there are other proteins that also

  • have transmembrane helices that somehow bind and sense

  • cholesterol that are going to help us

  • control cholesterol levels.

  • Now, what's really interesting about this--

  • so the protein is huge.

  • It's stuck in membrane.

  • What's really interesting is that you

  • can cut the protein in half, about in half.

  • That's what you're looking at there.

  • You have a soluble protein, they're

  • much easier to crystallize than membrane proteins.

  • And it turns out, if you cut the protein in half, this guy,

  • if you cut, is active.

  • And it's soluble.

  • And the activity is the same as the protein

  • bound to the membrane.

  • So it has very high activity.

  • So it's like you have two separate domains.

  • Furthermore, if you cut this in half,

  • you can still target this to the ER membrane,

  • and you can still sense cholesterol.

  • So somehow these two things have come together.

  • They have two really independent activities.

  • But we're going to see, they work together

  • to control cholesterol levels.

  • So what I want to do--

  • how am I doing?

  • Oh, see, time goes by too fast.

  • Isn't time going by too fast for you?

  • Anyhow, I want to show you--

  • and we'll come back to it next time--

  • is that the statins are the target of HMG-CoA reductase.

  • I mean, this is like an amazing thing.

  • Cholesterol biosynthesis was only elucidated in 1955.

  • And it turns out this guy, Endo, was the first one

  • to discover a natural product that somehow could

  • lower cholesterol in 1976.

  • And actually, when I was a young person,

  • Al Alberts used to work at Merck.

  • I used to consult for Merck back in those days.

  • It was incredibly exciting times,

  • because he discovered really sort

  • of the first real statin that worked, that wasn't toxic--

  • lovastatin.

  • And really, within a period of only seven years,

  • this was approved by the FDA.

  • So that's an amazing observation.

  • People are still gobbling down statins everywhere.

  • There are issues with them, but it makes $30 billion

  • for the companies that own this.

  • So you now might have heard of Lipitor or Crestor--

  • anyhow, they are there.

  • And it really is a wonder drug.

  • And it works, we're going to see next time.

  • Because it looks like the substrate

  • hydroxymethylglutaryl-CoA--

  • So that it acts as a competitive inhibitor

  • for binding to the active site of HMG-CoA reductase,

  • and prevents the reduction process.

  • And we'll come back next time and look

  • at a little bit at the details.

  • We're not going to spend a lot of time looking at the details,

  • but then finish on to get to IPP and dimethyl APP,

  • the building blocks we're after to make all terpenes.

  • OK.

The following content is provided under a Creative

字幕與單字

單字即點即查 點擊單字可以查詢單字解釋

B1 中級

19.膽固醇的生物合成1 (19. Cholesterol Biosynthesis 1)

  • 2 0
    林宜悉 發佈於 2021 年 01 月 14 日
影片單字